MOTS-c: The Mitochondrial Peptide and Cognitive Ageing
MOTS-c is a mitochondrial-derived peptide with emerging research into metabolic regulation and cognitive ageing. This overview covers the current science.
Disclaimer: This article is for research and educational purposes only. It does not constitute medical advice. Consult a qualified healthcare professional before making any health-related decisions.
Discovery of MOTS-c
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) was identified in 2015 by researchers at the University of Southern California, led by Pinchas Cohen. Its discovery was significant for two reasons: it represented the first peptide shown to be encoded within mitochondrial DNA (specifically the 12S rRNA gene), and it demonstrated that mitochondria — long considered passive energy generators — are active signalling organelles capable of producing bioactive peptides that regulate whole-body physiology.
The mature MOTS-c peptide consists of 16 amino acids (MRWQEMGYIFYPRKLR) and is found in both intracellular and circulating forms, allowing it to act in both autocrine and endocrine capacities. Plasma MOTS-c levels decline significantly with age in both humans and animal models, a finding that has fuelled research interest in its potential role as a longevity-associated molecule (PMID: 25738459).
AMPK Activation and Metabolic Regulation
The primary molecular target of MOTS-c is AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. AMPK acts as a cellular fuel gauge, activating energy-generating pathways and suppressing energy-consuming processes when cellular ATP is depleted. In metabolically active tissues including skeletal muscle, liver, and — critically — the brain, AMPK activity is central to maintaining energetic balance.
MOTS-c activates AMPK through a mechanism involving inhibition of the folate cycle and de novo purine synthesis pathway, leading to accumulation of AMP and subsequent AMPK phosphorylation. This positions MOTS-c as a metabolic stress sensor with downstream effects on glucose uptake, fatty acid oxidation, and mitochondrial biogenesis.
In the context of neuronal metabolism, AMPK activation by MOTS-c has important implications. AMPK promotes mitochondrial biogenesis through PGC-1α activation, increasing the density and efficiency of mitochondria in energy-demanding neurons. It also activates autophagy — the cellular cleaning process that removes damaged organelles and protein aggregates — which is impaired in ageing neurons and across neurodegenerative disease states.
Metabolic Stress Response
MOTS-c's role as a metabolic stress responder gives it particular relevance to the study of cognitive ageing. The brain under metabolic stress — whether from glucose deprivation, oxidative damage, or mitochondrial dysfunction — is more vulnerable to synaptic dysfunction and neurodegeneration. MOTS-c appears to enhance the brain's capacity to withstand and recover from metabolic challenges.
In rodent models of diet-induced metabolic dysfunction, MOTS-c administration improved insulin sensitivity, reduced neuroinflammation, and preserved hippocampal-dependent memory performance. The connection between insulin resistance and cognitive decline — sometimes referred to informally as type 3 diabetes in the context of Alzheimer's disease — makes MOTS-c's insulin-sensitising properties particularly relevant to research on cognitive ageing.
Retrotranslocation to the Nucleus
One of the more remarkable aspects of MOTS-c biology is its capacity for retrotranslocation — movement from the mitochondria into the nucleus in response to cellular stress. Once in the nucleus, MOTS-c acts as a transcriptional co-regulator, binding to antioxidant response elements (ARE) in the promoter regions of stress-response genes.
This nuclear activity allows MOTS-c to coordinate a comprehensive stress response that encompasses both mitochondrial and nuclear gene expression. The ARE-binding activity drives upregulation of antioxidant enzymes including superoxide dismutase (SOD) and haem oxygenase-1 (HO-1), enhancing cellular resilience to reactive oxygen species. This mechanism distinguishes MOTS-c from most conventional peptide signals and positions it as a genuinely novel class of mitochondria-to-nucleus communicator.
Implications for Neuronal Energy Regulation and Ageing
The convergence of MOTS-c's AMPK activation, nuclear stress response coordination, and age-related decline makes it a compelling research target in the context of cognitive ageing. Neurons are uniquely dependent on mitochondrial function due to their high energy demands and post-mitotic nature. The progressive decline in mitochondrial quality and function that characterises neuronal ageing — driven in part by declining mitochondrial-derived peptide signalling — represents a fundamental mechanism of cognitive deterioration.
MOTS-c supplementation in aged mouse models has demonstrated improvements in physical performance, metabolic health, and lifespan — findings that have prompted growing interest in its CNS effects. Early evidence from neurological research suggests that maintaining MOTS-c signalling may help preserve neuronal mitochondrial function and delay age-associated cognitive decline. For related mitochondrial peptide research, see our article on SS-31 and neurological research.
Research Access
Detailed documentation on MOTS-c research, including the emerging literature on its neurological applications, is available through the MOTS-c research guide at OzPeps.
For laboratory procurement, research-grade MOTS-c is available through OzPeps with purity verification. Given MOTS-c's relatively recent characterisation, sourcing from suppliers with rigorous quality control is particularly important for generating reproducible experimental data. RetaLABS is another source of research-grade MOTS-c for Australian researchers.
Summary
MOTS-c represents one of the most scientifically novel peptide discoveries of the past decade. As a mitochondria-encoded, AMPK-activating, nuclear-translocating signalling molecule, it occupies a unique position at the intersection of mitochondrial biology, metabolic regulation, and cognitive ageing research. Its age-related decline and demonstrated effects on metabolic resilience position it as a high-priority target for research into neuronal longevity and the prevention of age-related cognitive decline.